Whether you're looking to be treated, or just want a second opinion, Nebraska Medicine matches you up with a world-renowned lymphoma team. With an unsurpassed reputation for care, we treat patients from 5 continents and all 50 states.

We treat all the forms of lymphoma, which is a cancer that starts in white blood cells called lymphocytes. Lymphocytes are part of the immune system.

The two main types are Hodgkin's lymphoma and non-Hodgkin's lymphoma (NHL).

Hodgkin's lymphoma has unique cell characteristics that distinguish it from non-Hodgkin lymphoma, called the Reed-Sternberg cells.

Non-Hodgkin's lymphoma represents a diverse group of diseases distinguished by the characteristics of the cancer cells associated with each disease type. Most people with NHL have a B-cell type of NHL (about 85 percent). The others have a T-cell type or an NK-cell type of lymphoma.




Service Options

Patient Guides

The Highest Level of Treatment Methods

Our world renowned team works with you to choose the best possible care plan tailored to meet your needs.The choice of treatment often depends on how advanced the cancer is and whether or not it has favorable features.

Treatments may include:

New approaches for Hodgkin lymphoma are being study through clinical trials at Nebraska Medicine for newly diagnosed patients and patients with relapsed or refractory disease that hold the promise of increasing the rate of remission and finding a cure for all HL patients. The proportion of patients with HL, who enter into remission and stay in remission for years, has increased over the last three decades.


There are many types of lymphomas and each requires a customized treatment plan. We have a team of cancer doctors completely dedicated to lymphoma care and treatment. This ensures you will receive care from a team of experts who are familiar with the latest treatments and advancements and can apply them to your case. Our lymphoma team averages 150 to 160 bone and blood marrow transplants a year and have performed more than 4,800 transplants since the program's founding.

World Class Ground-Breaking Advancements

Doctors and researchers at Nebraska Medicine have been pioneers in the field and are recognized internationally for a number of ground-breaking advancements. This includes the study and introduction of autologous transplantation which uses a patient’s own stem cells to reduce rejection issues. Our innovative treatments have helped improve success rates and have made blood and marrow transplants a more viable and promising option for a growing number of patients. In fact, doctors from around the world call upon Nebraska Medicine’s lymphoma team for consultation.

Expertise Near You

The Nebraska Lymphoma Study Group (NLSG) brings community oncologists, pathologists and their counterparts together to provide the very best in lymphoma treatment to patients with Hodgkin disease, non-Hodgkin lymphoma and other neoplastic hematologic disorders. You have the opportunity to stay in your hometown to receive state-of-the-art treatment while having access to the expertise and resources of an academic health sciences center. Nearly 6,500 patients have been treated and more than 65,000 biopsies reviewed since the study group was formed in 1982.

A Team Approach

With the many different types of lymphoma, it is imperative that your cancer be properly identified so doctors can formulate the best treatment plan for you. To precisely diagnose your cancer, our hematopathologists - who are sought after nationally for their expertise - will carefully determine your specific type of lymphoma. A team of doctors, that may include medical oncologists, hematopathologists, radiation oncologists, surgical oncologists, advanced practice providers as well as other specialists in infectious disease and palliative care, meet regularly to discuss your case and develop a coordinated plan of care. Patients undergoing cancer treatment at Nebraska Medicine also have access to our 24/7 Infusion Center at the Peggy D. Cowdery Patient Care Center, which serves as both a treatment center and 24/7 urgent-care-type facility. A rare offering in the region.

Clinical Trials

Access to clinical trials affords patients the ability to participate in leading edge treatments that otherwise would not be available to them. You may qualify to participate in our latest lymphoma clinical trials, which may involve new drug options, chemotherapy treatments as well as radiation therapy. The latest discoveries made in research laboratories are incorporated into comprehensive lymphoma treatment plans, improving success rates. See what clinical trials related to lymphomas are going on right now. Talk to your care team to see if there are clinical trials you may qualify for.

Nebraska Medicine is also part of the National Institutes of Health/National Cancer Institute Bone Marrow Transplant Clinical Trials Network – a consortium transplant centers across the country that collaborate on clinical trials to derive data from a larger population of patients and to allow for greater sharing of information between centers. Through this network, doctors can study and refine their techniques to diagnose, treat and follow patients to provide them with optimal care.

For Academic Inquiries Call 402.559.8500

Accreditations and Awards





The American Society of Clinical Oncology Quality Oncology Practice Initiative

Nebraska Medicine has been recognized by the Quality Oncology Practice Initiative (QOPI®) Certification Program, an affiliate of the American Society of Clinical Oncology. The QOPI® Certification Program (QCP™) certifies oncology practices that meet nationally recognized standards for cancer care. This certification reaffirms our commitment to providing patients with high quality cancer care. For more information, please visit:



Blue Cross Blue Shield of Nebraska Blue Distinction Center+

Blue Distinction Centers and Blue Distinction Centers+ have a proven history of delivering exceptional care and results. Nebraska Medicine has received Blue Distinction in adult and pediatric bone marrow/stem cell patient care.



Foundation for the Accreditation of Cellular Therapy (FACT)

FACT Accreditation demonstrates our commitment to quality in cellular therapy and blood and marrow transplantation and verifies that our transplant program has met rigorous international standards.

Nationally Ranked

U.S. News & World Report has ranked Nebraska Medicine as one of the best cancer centers for several years. We are also a National Comprehensive Cancer Network member, which means we are part of an alliance of the nation’s leading cancer centers that focuses on improving patient care. As a National Cancer Institute-designated Cancer Center, Nebraska Medicine is known for its clinical trials and ground-breaking research.